Clinical trial
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
NCT00376103 · Methodist Healthcare, Other · Terminated
Key facts
| NCT number | NCT00376103 |
|---|---|
| Title | Radiation Boost for Newly Diagnosed Glioblastoma Multiforme |
| Official title | A Phase I/II Trial of Maximal Resection, Local Radiation Boost With Concomitant Temozolomide, Followed by External Radiation Therapy With Concomitant Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme |
| Lead sponsor | Methodist Healthcare, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma Multiforme |
| Intervention type | Drug, Procedure |
| Interventions | temozolomide, Brachytherapy, External Beam Radiation Therapy |
| Enrollment | 3 |
| Start date | Aug 1, 2006 |
| Primary completion | Mar 1, 2008 |
| First posted | Sep 14, 2006 |
| Last update posted | Sep 18, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: